Skip to main content
Premium Trial:

Request an Annual Quote

NIDA to Offer Free DNA Genotyping for Substance Abuse Research

NEW YORK (GenomeWeb) – The National Institute on Drug Abuse is offering researchers free genotyping services for existing extracted DNA samples from individuals with substance abuse disorders, the National Institutes of Health announced last week.

According to the NIDA, the Center for Genetic Studies at the Rutgers University-based biorepository RUCDR Infinite Biologics will genotype samples submitted on BioRealm's SmokeScreen Genotyping array.

The resulting data will be stored in the National Center of Biotechnology Information's database of Genotypes and Phenotypes for six months, during which time the investigators who submitted the samples will be able to analyze their data. After this period, the data will be publicly released per the NIH's Genome Data Sharing Policy.

Requests for genotyping must be received no later than April 1, and proposed samples must be approved by the NIDA, the NIH said. Additional details can be found here.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.